Answers are grounded in this paper and cite their sources.
We evaluated the new low-cost ExaVir Load (version 3) reverse transcriptase viral load assay against the Roche Cobas Amplicor assay. Results for samples tested using the reverse transcriptase assay correlated well with those obtained with the Roche assay (r = 0.85; n = 202). The version 3 reverse transcriptase assay shows improved sensitivity compared to the previous version.
No takes yet. Share an insight, caveat, or question.
Greengrass et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: